Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Pandey

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
BMC Cancer|January 29, 2013
Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinomaZheng-Sheng Wu, Vijay Pandey, Wen-Yong Wu, et al.
Molecules (Basel, Switzerland)|February 6, 2021
Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma CellsBasappa Basappa, Baburajeev Chumadathil Pookunoth, Mamatha Shinduvalli Kempasiddegowda, et al.
Breast Cancer Research : BCR|October 1, 2014
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinomaVijay Pandey, Zheng-Sheng Wu, Min Zhang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 1, 2021
Mitochondria: The metabolic switch of cellular oncogenic transformationYan Qin Tan, Xi Zhang, Shuwei Zhang, et al.
Oncogene|December 10, 2024
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinomaShuwei Zhang, Yan Qin Tan, Xi Zhang, et al.
Cell Death & Disease|February 7, 2025
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinomaChuyu He, Xuejuan Wang, Yi-Shiou Chiou, et al.
Translational Oncology|August 24, 2024
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancerLiqiong Wang, Xi Zhang, Shu Chen, et al.
Cell Death & Disease|June 20, 2022
Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinomaXi Zhang, Peng Huang, Liqiong Wang, et al.
Cancer Letters|January 11, 2021
Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectivesVipul Bhardwaj, Yan Qin Tan, Ming Ming Wu, et al.
Plos One|November 13, 2015
Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2Wai-Hoe Lau, Vijay Pandey, Xiangjun Kong, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
BMC Cancer|January 29, 2013
Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinomaZheng-Sheng Wu, Vijay Pandey, Wen-Yong Wu, et al.
Molecules (Basel, Switzerland)|February 6, 2021
Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma CellsBasappa Basappa, Baburajeev Chumadathil Pookunoth, Mamatha Shinduvalli Kempasiddegowda, et al.
Breast Cancer Research : BCR|October 1, 2014
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinomaVijay Pandey, Zheng-Sheng Wu, Min Zhang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 1, 2021
Mitochondria: The metabolic switch of cellular oncogenic transformationYan Qin Tan, Xi Zhang, Shuwei Zhang, et al.
Oncogene|December 10, 2024
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinomaShuwei Zhang, Yan Qin Tan, Xi Zhang, et al.
Cell Death & Disease|February 7, 2025
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinomaChuyu He, Xuejuan Wang, Yi-Shiou Chiou, et al.
Translational Oncology|August 24, 2024
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancerLiqiong Wang, Xi Zhang, Shu Chen, et al.
Cell Death & Disease|June 20, 2022
Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinomaXi Zhang, Peng Huang, Liqiong Wang, et al.
Cancer Letters|January 11, 2021
Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectivesVipul Bhardwaj, Yan Qin Tan, Ming Ming Wu, et al.
Plos One|November 13, 2015
Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2Wai-Hoe Lau, Vijay Pandey, Xiangjun Kong, et al.
Pageof 10